WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve With reference to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, a meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Limited will be held on Wednesday, 14th February, 2024 at 3:00 P.M., at the registered office of the company, inter alia to transact the following matters: 1. To consider, approve the un-audited Financial Results of the Company for the Quarter ended 31st December, 2023. 2. Any other business as may be considered necessary. We further wish to inform you that as per requirement, the Trading Window of Equity Shares of the Company shall reopen on 17th February, 2024.